ViviGen MIS is the first cellular allograft optimized for minimally invasive surgeries, and it has been successfully used in minimally invasive spine procedures.
ViviGen includes a pre-filled cannula and sterile delivery device that allows bone allografts to be delivered with efficiency, reliability and precision.
Compared to a bone graft funnel, ViviGen offers better graft preparation and delivery performance, resulting in procedures that are three times faster, according to a March 8 press release.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.